TY - JOUR
T1 - The Development of Health Technology Assessment in Asia
T2 - Current Status and Future Trends
AU - Liu, Gordon
AU - Wu, Eric Q.
AU - Ahn, Jeonghoon
AU - Kamae, Isao
AU - Xie, Jipan
AU - Yang, Hongbo
N1 - Publisher Copyright:
© 2019 ISPOR–The professional society for health economics and outcomes research
PY - 2020/5
Y1 - 2020/5
N2 - Health technology assessment (HTA) has long been employed by many countries around the world, but its adoption in Asia has been slower. Only recently have a growing number of Asian countries started to implement HTA for pricing and reimbursement decisions. The objective of this article is to provide an overview of how HTA has been or is being implemented in Asia within the context of a country's existing—and often complex—coverage, reimbursement, and pricing schemes. Three countries at different stages of HTA implementation were selected as case studies: South Korea, where there is a young yet established HTA program; Japan, where a 3-year HTA pilot program has just concluded; and China, where HTA efforts are underway but have not been formally implemented. Not only do the experiences of these 3 countries well exemplify how the organization and scope of HTA can be customized to meet a country's unique healthcare needs, but they also provide the opportunity to outline some common key challenges that must be overcome to implement and develop HTA competencies and capabilities.
AB - Health technology assessment (HTA) has long been employed by many countries around the world, but its adoption in Asia has been slower. Only recently have a growing number of Asian countries started to implement HTA for pricing and reimbursement decisions. The objective of this article is to provide an overview of how HTA has been or is being implemented in Asia within the context of a country's existing—and often complex—coverage, reimbursement, and pricing schemes. Three countries at different stages of HTA implementation were selected as case studies: South Korea, where there is a young yet established HTA program; Japan, where a 3-year HTA pilot program has just concluded; and China, where HTA efforts are underway but have not been formally implemented. Not only do the experiences of these 3 countries well exemplify how the organization and scope of HTA can be customized to meet a country's unique healthcare needs, but they also provide the opportunity to outline some common key challenges that must be overcome to implement and develop HTA competencies and capabilities.
KW - Asia
KW - global healthcare systems
KW - health technology assessment
KW - value assessment
UR - http://www.scopus.com/inward/record.url?scp=85073435116&partnerID=8YFLogxK
U2 - 10.1016/j.vhri.2019.08.472
DO - 10.1016/j.vhri.2019.08.472
M3 - Article
C2 - 31634795
AN - SCOPUS:85073435116
SN - 2212-1099
VL - 21
SP - 39
EP - 44
JO - Value in Health Regional Issues
JF - Value in Health Regional Issues
ER -